Streetbeat News

Stock Prices

MNST

Monster Beverage shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:24 pm

KROS

Keros Therapeutics (NASDAQ:KROS) reported Q2 earnings per share (EPS) of $(1.25), missing the analyst consensus estimate of $(1.23) by 1.63%. This represents a slight improvement from the $(1.27) per share loss in the same period last year. The company also reported $37.00 thousand in sales for the quarter.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:24 pm

GH

Guardant Health has raised its FY24 revenue outlook excluding screening from $675M-$685M to $690M-$700M. The company expects non-GAAP gross margin excluding screening to be 61%-63% and total non-GAAP operating expenses to be $720-$730 million, representing a flat to 1% decrease compared to 2023. Free cash flow is expected to be $(275)-$(285) million, an improvement of $60M-$70M compared to 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:23 pm

BTCUSD

DOGEUSD

ETHUSD

SHIBUSD

SOLUSD

Cryptocurrency markets are down on Wednesday due to broader economic concerns and geopolitical tensions. Bitcoin (BTC) could dip to $54,500 if it breaks the $56,800 support level. Ethereum (ETH), Dogecoin (DOGE), Solana (SOL), and Shiba Inu (SHIB) also saw declines. Notable developments include Bitcoin whales accumulating $23B worth of BTC and Morgan Stanley offering Spot Bitcoin ETFs to clients.

Portfolio Pulse from Khyathi Dalal

August 07, 2024 | 8:23 pm

HOOD

Robinhood Markets (NASDAQ:HOOD) reported strong Q2 earnings with revenue and EPS beating estimates. Key highlights include a 161% increase in crypto revenue, 2 million Gold subscribers, and record net deposits of $13.2 billion. The company also reported a 57% increase in assets under custody.

Portfolio Pulse from Chris Katje

August 07, 2024 | 8:22 pm

CACI

CACI International has provided its fiscal year 2025 guidance, forecasting adjusted EPS between $22.44 and $23.33, slightly below the $23.30 estimate. Revenue is expected to be between $7.9 billion and $8.1 billion, aligning closely with the $7.91 billion estimate. The company also projects free cash flow of at least $425 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:22 pm

OM

Outset Medical shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:22 pm

ESE

ESCO Technologies has provided its FY24 adjusted EPS guidance in the range of $4.10 to $4.20, which is below the analyst estimate of $4.24.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:22 pm

ESE

ESCO Technologies has announced its Q4 adjusted EPS guidance to be between $1.38 and $1.48, significantly higher than the estimated $1.20.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:22 pm

UPWK

Upwork has released its Q3 2024 revenue guidance, projecting $179M-$184M, which is below the $193M estimate. The company also expects adjusted EPS to be $0.23-$0.25, in line with the $0.23 estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:21 pm